Research News

Kip Connor, PhD, with funding from Macular Degeneration Research (MDR), has lead a team of experts to discover an important role of immune cells that regulate, and could potentially stop, abnormal blood vessel growth in advanced age-related macular degeneration (AMD).

Francis Hanes, PhD, is using his knowledge of biophysics to advance Alzheimer’s imaging and achieve earlier diagnosis. Read about his BrightFocus-funded research.

Learn about an exciting citizen science project receiving support from the BrightFocus Alzheimer’s Disease Research program; the first crowd-sourced effort to gather data to help end Alzheimer’s disease.

Top U.S. scientists are concerned that eye and vision health are relatively absent from national health priority lists. AMD, in particular, is rising..

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.

Jeffrey Goldberg, MD, PhD, a BrightFocus grantee answers questions about an exciting new clinical trial for glaucoma.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

BrightFocus Foundation today lauded a new, innovative citizen science project, EyesOnALZ, which recently launched an online game - Stall Catchers - to engage the public in helping researchers analyze Alzheimer’s data in the hopes of more quickly discovering ways to prevent and treat the disease.

BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Initiative, AnthroTronix, and Mindoula, have launched Phase II of the Health-eBrain Study, investigating the impact the Alzheimer’s caregiving experience has on brain and behavioral health.